INFLAMMATORY MARKERS IN NEONATAL SEPSIS
Background: There is still an urgent medical need for the diagnosis of hyperinflammation associated with sepsis in the newborn. In the case of neonatal sepsis, everything is complicated by many factors that affect the biomarker analysis: a large variability in the degree of maturity at birth, features of the functioning of all organs and systems, and especially the immune system.
Aim: Our research is devoted to the study of biomarkers of inflammation in early neonatal sepsis.
Materials and methods: Observational cohort study. In the study up to 75 newborns treated in intensive care units are included. The criterion for defining a case of "sepsis" was a positive blood culture. The control group consisted of children with negative blood culture, who were treated in the intensive care unit. We used bacteriological and immunological research methods (flow cytometry for cell markers, immunofluorescence analysis of cytokines)
Statistical analysis was performed using the non-parametric Kruskal-Wallis test, Mann-Whitney test with Holm correction (R statistics). Categorical data were calculated using the Chi-square test.
Results: C reactive protein showed a good applicability in the case of early neonatal sepsis, in contrast to procalcitonin, which demonstrates an excellent specificity, has a low sensitivity and high variability.
Neither leukocytosis, leukopenia, leukocyte subpopulations showed reliable discriminatory characteristics. However, a simple and publicly available neutrophil-lymphocyte index presented 80% specificity and generally proved to be a reliable index. The basic immune status is characterized only by a decrease in CD8 lymphocytes. Cytokines are standard markers of inflammation; however, it is difficult to obtain meaningful differences due to the abundance of cofactors that affect their levels. But at the same time, sCD40 and IL-17a, which have not been sufficiently studied in neonatal sepsis, should be recognized as extremely promising.
Conclusions: The study of inflammation markers of early neonatal sepsis showed that hyperinflammatory syndrome prevails in the pathogenesis of neonatal sepsis. Significant variation in serum markers of newborns, including the classic ones (CRP, PCT, NRL, interleukins 6, 8), suggests that they should be used with caution for diagnosis. There is a need to study new new diagnostic targets based on markers of inflammation. According to the results of our study, sCD40 and IL-17a, which were previously insufficiently studied in neonatal sepsis, should be recognized as such targets as extremely promising markers.
Lydmila L. Akhmaltdinova1,2, https://orcid.org/0000-0001-5602-6136
Svetlana I. Kolesnichenko 1, https://orcid.org/0000-0003-3515-8900
Alena V. Lavrinenko1, https://orcid.org/0000-0001-9436-8778
Zhibek A. Zhumadilova1, https://orcid.org/0000-0003-3227-1692
Olga V. Avdienko1, https://orcid.org/0000-0001-9122-1279
Lyudmila G. Panibratec3, Elena V. Vinogradskaya4
1 NJSC «Medical University of Karaganda», Karaganda, Republic of Kazakhstan;
2 NJSC «National Scientific Cardiac Surgery Center», Nur-Sultan, Republic of Kazakhstan;
3 Regional Clinical Hospital "Perinatal Center No. 2, Karaganda, Republic of Kazakhstan;
4 Regional Clinical Hospital" Perinatal Center No. 1, Karaganda, Republic of Kazakhstan.
1. Здоровье населения Республики Казахстан и деятельность организаций здравоохранения в 2019 году: Статистический сборник. // Министерство здравоохранения РК Астана, 2020, 01.07.2020., 323 с.
2. Танцюра Л.Д. Прокальцитонин у новорожденных детей. Неоднозначность оценки // Современная педиатрия. 2018. №5(93). С.37-41.
3. Чурсина Е.С., Дементьева Г.М. Прокальцитонин и его значение как маркера тяжелых бактериальных инфекций у новорожденных детей // Российский вестник перинатологии и педиатрии. 2007. №6. С.21-26.
4. Alkan Ozdemir S., Arun Ozer E., Ilhan O., Sutcuoglu S. Can neutrophil to lymphocyte ratio predict late-onset sepsis in preterm infants? // J. Clin. Lab. Anal. 2018. №32(4). e22338.
5. Can E., Hamilcikan S., Ca C. The Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio for Detecting Early-onset Neonatal Sepsis // J. Pediatr. Hematol. Oncol., 2018. №40(4). e229-e232.
6. Gilfillan M., Bhandari V. Neonatal sepsis biomarkers: where are we now? // Research and Reports in Neonatology. 2019. №9. P.9-20.
7. Hincu M.-A., Zonda G.-I., Stanciu G.D., Nemescu D., Paduraru L. Relevance of Biomarkers Currently in Use or Research for Practical Diagnosis Approach of Neonatal Early-Onset Sepsis // Children. 2020. №7. Р.309.
8. Hotchkiss R.S., Monneret G., Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach // Lancet Infect Dis. 2013. №13. Р.260–268.
9. Khan F. C-reactive Protein as a Screening Biomarker in Neonatal Sepsis // J Coll Physicians Surg Pak. 2019. №29(10). Р.951-953.
10. Li T., Dong G., Zhang M., Xu Z., Hu Y., et al Association of Neutrophil-Lymphocyte Ratio and the Presence of Neonatal Sepsis // J Immunol Res. 2020. №2. 2020. 7650713. doi: 10.1155/2020/7650713.
11. Nakamori Y., Park E.J., Shimaoka M. Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway // Front. Immunol. 2021. Article 624279.
12. Odabasi I.O., Bulbul A. Neonatal Sepsis. Sisli Etfal Hastan // Tip Bul. 2020. №54. Р.142-158.
13. Philip A.G., Hewitt J.R. Early diagnosis of neonatal sepsis // Pediatrics. 1980. №65. Р.1036–1041.
14. Ruan L., Chen G.Y., Liu Z., Zhao Y., Xu G.Y. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review // Crit Care. 2018. № 22(1). Р.316.
15. Sharma D., Farahbakhsh N., Shastri S., Sharma P. Biomarkers for diagnosis of neonatal sepsis: a literature review // J Matern Fetal Neonatal Med. 2018. № 31(12). Р.1646-1659.
References:
1. Zdorov'e naseleniya Respubliki Kazakhstan i deyatel'nost' organizatsii zdravookhraneniya v 2019 godu: Statisticheskii sbornik [Health of the population of the Republic of Kazakhstan and the activities of healthcare organizations in 2019: statistical collection]. Ministerstvo zdravookhraneniya RK [Ministry of Health]. Astana, 2020, 323 p. [in Russian]
2. Tancjura L.D. Prokal'tsitonin u novorozhdennykh detei. Neodnoznachnost' otsenki [Procaltsitonin in newborns. Uncertainty of assessment]. Sovremennaya pediatriya [Modern pediatrics]. 2018, №5(93), pp. 37-41. [in Russian]
3. Chursina E.S. Dement'eva G.M. Prokal'tsitonin i ego znachenie kak markera tjazhelykh bakterial'nykh infektsii u novorozhdennykh detei [Procalcitonin and its significance as a marker of severe bacterial infections in newborns]. Rossiiskii vestnik perinatologii i pediatrii [Russian Bulletin of Perinatology and Pediatrics]. 2007, №6, pp.21-26 [in Russian].
Number of Views: 109
Category of articles:
Original articles
Bibliography link
Akhmaltdinova L.L., Kolesnichenko S.I., Lavrinenko A.V., Zhumadilova Zh.A., Avdienko O.V., Panibratec L.G., Vinogradskaya E.V. Inflammatory markers in neonatal sepsis // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 4, pp. 44-50. doi 10.34689/SH.2022.24.4.006Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS